Search Results - "Toyota, Tokuko"

iPSC-Derived Neoantigen-Specific CTL Therapy for Ewing Sarcoma by Ishii, Midori, Ando, Jun, Yamazaki, Satoshi, Toyota, Tokuko, Ohara, Kazuo, Furukawa, Yoshiki, Suehara, Yoshiyuki, Nakanishi, Mahito, Nakashima, Kazutaka, Ohshima, Koichi, Nakauchi, Hiromitsu, Ando, Miki

“…The prognosis of Ewing sarcoma caused by fusion is poor, especially after metastasis. Although therapy with CTLs targeted against altered EWS/FLI1 sequences at…”
Get more information

Dasatinib-induced anti-leukemia cellular immunity through a novel subset of CD57 positive helper/cytotoxic CD4 T cells in chronic myelogenous leukemia patients by Watanabe, Naoki, Takaku, Tomoiku, Takeda, Kazuyoshi, Shirane, Shuichi, Toyota, Tokuko, Koike, Michiaki, Noguchi, Masaaki, Hirano, Takao, Fujiwara, Hiroshi, Komatsu, Norio

“…Dasatinib induces lymphocytosis of large granular lymphocytes (LGLs) in a proportion of patients with chronic myelogenous leukemia (CML), and is associated…”
Get full text

Establishment of ganglioside GD2-expressing extranodal NK/T-cell lymphoma cell line with scRNA-seq analysis by Sato, Shoko, Ishii, Midori, Tachibana, Kota, Furukawa, Yoshiki, Toyota, Tokuko, Kinoshita, Shintaro, Azusawa, Yoko, Ando, Jun, Ando, Miki

“…•A novel GD2+ extranodal NK/T-cell lymphoma cell line, ENKL-J1, was established.•GD2-CART cells exhibited robust cytotoxicity for ENKL-J1 cells in vitro and in…”
Get full text

Dual-antigen targeted iPSC-derived chimeric antigen receptor-T cell therapy for refractory lymphoma by Harada, Sakiko, Ando, Miki, Ando, Jun, Ishii, Midori, Yamaguchi, Tomoyuki, Yamazaki, Satoshi, Toyota, Tokuko, Ohara, Kazuo, Ohtaka, Manami, Nakanishi, Mahito, Shin, Chansu, Ota, Yasunori, Nakashima, Kazutaka, Ohshima, Koichi, Imai, Chihaya, Nakazawa, Yozo, Nakauchi, Hiromitsu, Komatsu, Norio

“…We generated dual-antigen receptor (DR) T cells from induced pluripotent stem cells (iPSCs) to mitigate tumor antigen escape. These cells were engineered to…”
Get full text

Sustainable Tumor-Suppressive Effect of iPSC-Derived Rejuvenated T Cells Targeting Cervical Cancers by Honda, Tadahiro, Ando, Miki, Ando, Jun, Ishii, Midori, Sakiyama, Yumi, Ohara, Kazuo, Toyota, Tokuko, Ohtaka, Manami, Masuda, Ayako, Terao, Yasuhisa, Nakanishi, Mahito, Nakauchi, Hiromitsu, Komatsu, Norio

“…Immunotherapy utilizing induced pluripotent stem cell (iPSC) technology has great potential. Functionally rejuvenated cytotoxic T lymphocytes (CTLs) can…”
Get full text

iPSC-derived hypoimmunogenic tissue resident memory T cells mediate robust anti-tumor activity against cervical cancer by Furukawa, Yoshiki, Ishii, Midori, Ando, Jun, Ikeda, Kazuya, Igarashi, Kyomi J, Kinoshita, Shintaro, Azusawa, Yoko, Toyota, Tokuko, Honda, Tadahiro, Nakanishi, Mahito, Ohshima, Koichi, Masuda, Ayako, Yoshida, Emiko, Kitade, Mari, Porteus, Matthew, Terao, Yasuhisa, Nakauchi, Hiromitsu, Ando, Miki

“…Functionally rejuvenated human papilloma virus-specific cytotoxic T lymphocytes (HPV-rejTs) generated from induced pluripotent stem cells robustly suppress…”
Get full text